| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
ConvaTec Group Plc (LSE: CTEC)
CTEC Technical Analysis
1.5
| As on 2nd Jul 2025 CTEC STOCK Price closed @ 257.40 and we RECOMMEND Buy for LONG-TERM with Stoploss of 245.54 & Sell for SHORT-TERM with Stoploss of 259.20 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CTECSTOCK Price
| Open | 270.00 | Change | Price | % |
| High | 270.60 | 1 Day | -14.60 | -5.37 |
| Low | 250.20 | 1 Week | -32.40 | -11.18 |
| Close | 257.40 | 1 Month | -17.60 | -6.40 |
| Volume | 15005792 | 1 Year | 12.40 | 5.06 |
| 52 Week High 295.40 | 52 Week Low 213.40 | ||||
LSE UK Most Active Stocks
| MIRI | 0.01 | 0.00% |
| PREM | 0.01 | 0.00% |
| UKOG | 0.01 | 0.00% |
| MSMN | 0.02 | 0.00% |
| VRS | 0.02 | 0.00% |
| CPX | 0.29 | 11.54% |
| DEMG | 0.02 | -50.00% |
| ENET | 0.02 | 0.00% |
| TIR | 0.34 | -17.07% |
| LLOY | 73.54 | -3.69% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
| CTEC Daily Charts |
CTEC Intraday Charts |
Whats New @ Bazaartrend |
CTEC Free Analysis |
|
|
CTEC Important Levels Intraday
| RESISTANCE | 296.71 |
| RESISTANCE | 284.10 |
| RESISTANCE | 276.31 |
| RESISTANCE | 268.52 |
| SUPPORT | 246.28 |
| SUPPORT | 238.49 |
| SUPPORT | 230.70 |
| SUPPORT | 218.09 |
CTEC Forecast July 2025
| 4th UP Forecast | 295.55 |
| 3rd UP Forecast | 283.32 |
| 2nd UP Forecast | 275.75 |
| 1st UP Forecast | 268.19 |
| 1st DOWN Forecast | 246.61 |
| 2nd DOWN Forecast | 239.05 |
| 3rd DOWN Forecast | 231.48 |
| 4th DOWN Forecast | 219.25 |
CTEC Weekly Forecast
| 4th UP Forecast | 275.90 |
| 3rd UP Forecast | 269.97 |
| 2nd UP Forecast | 266.30 |
| 1st UP Forecast | 262.63 |
| 1st DOWN Forecast | 252.17 |
| 2nd DOWN Forecast | 248.50 |
| 3rd DOWN Forecast | 244.83 |
| 4th DOWN Forecast | 238.90 |
CTEC Forecast2025
| 4th UP Forecast | 448.94 |
| 3rd UP Forecast | 387.51 |
| 2nd UP Forecast | 349.54 |
| 1st UP Forecast | 311.57 |
| 1st DOWN Forecast | 203.23 |
| 2nd DOWN Forecast | 165.26 |
| 3rd DOWN Forecast | 127.29 |
| 4th DOWN Forecast | 65.86 |
ConvaTec Group Plc ( LSE UK Symbol : CTEC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CTEC Business Profile
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urological catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products use in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to the manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospitals and the home healthcare sector. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom. Address: 3 Forbury Place, Reading, United Kingdom, RG1 3JH
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service